Nivolumab,ipilimumab
bms
['nivo', 'cam ']
dr richard quek presented #wcd2023singapore on treatment of advanced melanoma good news - mean survival is 6 years bad news - 60% of patients will experience significant toxicity 
A society of scientists and research-orientated clinicians whose aim is to promote, support and promulgate research in dermatology and cutaneous biology.